Maha Katabi, Director at Vera Therapeutics, holds 2.79M shares in Vera Therapeutics (Ticker: VERA), holds 0.00 shares in RayzeBio, Inc. (Ticker: RYZB), holds 3.76M shares in Aerovate Therapeutics (Ticker: AVTE). Most recently, Maha Katabi Sold ― shares of Vera Therapeutics on Mar 25, 2024 for an estimated value of 34.10M.